Capital International, Inc. Elanco Animal Health Inc Transaction History

Capital International, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$16.68 - $32.25 $3.89 Million - $7.52 Million	-233,054 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$25.29 - $29.45 $779,437 - $907,649	-30,820 Reduced 11.68%	233,054 $6.86 Million
Q3 2019 Nov 14, 2019	BUY	$25.62 - $34.96 $5.15 Million - $7.03 Million	201,138 Added 320.61%	263,874 $7.02 Million
Q2 2019 Aug 14, 2019	SELL	$31.11 - $34.79 $754,853 - $844,144	-24,264 Reduced 27.89%	62,736 $2.12 Million
Q1 2019 May 15, 2019	BUY	$29.0 - $32.83 $1.01 Million - $1.15 Million	34,927 Added 67.07%	87,000 $2.79 Million
Q4 2018 Feb 14, 2019	BUY	$29.63 - $34.5 $713,282 - $830,518	24,073 Added 85.98%	52,073 $1.64 Million
Q3 2018 Nov 14, 2018	BUY	$34.1 - $36.19 $954,800 - $1.01 Million	28,000 New	28,000 $977,000

439

480M

3.1M

1.26M

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.01B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

Stay updated on Capital International, Inc. with notifications on news.